Antiendotoxin activity of cationic peptide antimicrobial agents.

Infection and Immunity
M GoughN M Kelly

Abstract

The endotoxin from gram-negative bacteria consists of a molecule lipopolysaccharide (LPS) which can be shed by bacteria during antimicrobial therapy. A resulting syndrome, endotoxic shock, is a leading cause of death in the developed world. Thus, there is great interest in the development of antimicrobial agents which can reverse rather than promote sepsis, especially given the recent disappointing clinical performance of antiendotoxin therapies. We describe here two small cationic peptides, MBI-27 and MBI-28, which have both antiendotoxic and antibacterial activities in vitro and in vivo in animal models. We had previously demonstrated that these peptides bind to LPS with an affinity equivalent to that of polymyxin B. Consistent with this, the peptides blocked the ability of LPS and intact cells to induce the endotoxic shock mediator, tumor necrosis factor (TNF), upon incubation with the RAW 264.7 murine macrophage cell line. MBI-28 was equivalent to polymyxin B in its ability to block LPS induction of TNF by this cell line, even when added 60 min after the TNF stimulus. Furthermore, MBI-28 offered significant protection in a galactosamine-sensitized mouse model of lethal endotoxic shock. This protection correlated with the ab...Continue Reading

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C GalanosW Reutter
Feb 1, 1989·The Journal of Infectious Diseases·P BrandtzaegE Sørensen
Nov 9, 1985·Lancet·J Cohen, J S McConnell
Mar 1, 1983·Infection and Immunity·S J CryzR Germanier
Apr 7, 1995·Science·W J ChristM A Mullarkey
Jul 1, 1994·Annals of Surgery·M A RogyS F Lowry
Aug 1, 1994·The Journal of Clinical Investigation·O LevyP Elsbach
Jan 1, 1995·Advances in Microbial Physiology·R E HancockM Brown

❮ Previous
Next ❯

Citations

Sep 4, 1998·The Journal of Peptide Research : Official Journal of the American Peptide Society·M E HoustonR E Hancock
Jun 19, 2001·Biological Chemistry·W van 't HofA V Amerongen
Nov 30, 2002·Expert Opinion on Investigational Drugs·Sanjay ManochaAnand Kumar
Oct 18, 2003·American Journal of Respiratory and Critical Care Medicine·Andrea GiacomettiGiorgio Scalise
Jan 26, 2005·American Journal of Respiratory Cell and Molecular Biology·Jonathan W McMichaelJean-Michel Sallenave
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Dawn M E BowdishRobert E W Hancock
Jul 5, 2005·Expert Opinion on Investigational Drugs·R E Hancock
Jan 31, 2006·Chembiochem : a European Journal of Chemical Biology·Söhnke VossRoland Brock
Jun 14, 2008·Expert Opinion on Investigational Drugs·Matthew E Falagas, Petros I Rafailidis
Apr 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R López-RojasJ Pachón
Oct 22, 2011·International Journal of Molecular Sciences·Seong-Cheol ParkKyung-Soo Hahm
Sep 8, 2012·Future Microbiology·Alexandra K MarrW Robert McMaster
Nov 20, 2016·Clinical Pharmacology and Therapeutics·P MatznellerM Zeitlinger
Oct 28, 2019·Protein and Peptide Letters·Ambika SharmaSimmi Singh
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M G ScottR E Hancock
Jul 12, 2001·Infection and Immunity·F S BrinkmanR E Hancock
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hun Sik KimSun Chang Kim
Mar 18, 2005·The Journal of Antimicrobial Chemotherapy·F JacobsenL Steinstraesser
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E Falagas, Sofia K Kasiakou
Mar 6, 2002·The Journal of Experimental Medicine·Mathias W HornefAgneta Richter-Dahlfors
Jun 12, 2003·Journal of Chemotherapy·A GiacomettiG Scalise
Jul 19, 2006·Clinical Microbiology Reviews·Håvard JenssenRobert E W Hancock
Jan 26, 2010·American Journal of Respiratory Cell and Molecular Biology·Peter G BarlowDonald J Davidson
May 9, 2012·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Mehdi Kazemzadeh-NarbatRizhi Wang
Oct 16, 2013·Expert Review of Anti-infective Therapy·Kim A BrogdenShireen Vali
Jan 21, 2015·International Journal of Dermatology·Hee-Sun LimSeong-Jin Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.